Esperion Therapeutics Inc (NASDAQ:ESPR)

105.24
Delayed Data
As of Apr 01
 +12.64 / +13.65%
Today’s Change
12.75
Today|||52-Week Range
118.95
+160.24%
Year-to-Date

Today’s Trading

Previous close92.60
Today’s open96.99
Day’s range-- - --
Volume2,572,085
Average volume (3 months)872,508
Market cap$2.1B
Dividend yield--
Data as of 04/01/2015

Growth & Valuation

Earnings growth (last year)+32.93%
Earnings growth (this year)-5.18%
Earnings growth (next 5 years)-27.02%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book14.11

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc+0.03+0.36%
HALOHalozyme Therapeutic...+0.39+2.73%
KITEKite Pharma Inc-2.01-3.48%
OPHTOphthotech Corp-0.05-0.11%
Data as of 04/01/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$0.00
Annual profit (last year)-$36.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Scientific Officer
Roger S. Newton
President, Chief Executive Officer &
Director
Tim M. Mayleben
Corporate headquarters
Ann Arbor, Michigan

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account